News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
303,530 Results
Type
Article (11501)
Company Profile (127)
Press Release (291902)
Section
Business (101823)
Career Advice (734)
Deals (17144)
Drug Delivery (46)
Drug Development (25144)
Employer Resources (39)
FDA (5250)
Job Trends (7643)
News (151987)
Policy (12366)
Tag
Academia (1318)
Alliances (30503)
Alzheimer's disease (498)
Approvals (5238)
Artificial intelligence (90)
Bankruptcy (136)
Best Places to Work (6544)
Biotechnology (88)
Breast cancer (59)
Cancer (474)
Career advice (624)
Cell therapy (78)
Clinical research (19650)
Collaboration (258)
Compensation (120)
COVID-19 (819)
C-suite (49)
Data (470)
Diabetes (48)
Diagnostics (3479)
Drug discovery (48)
Drug pricing (53)
Earnings (33541)
Events (40891)
Executive appointments (166)
FDA (5495)
Funding (167)
Gene therapy (56)
GLP-1 (207)
Government (2275)
Healthcare (10481)
Infectious disease (846)
Inflammatory bowel disease (50)
Interviews (111)
IPO (7483)
Job creations (1328)
Job search strategy (542)
Layoffs (111)
Legal (2443)
Lung cancer (64)
Manufacturing (108)
Medical device (5294)
Medtech (5296)
Mergers & acquisitions (9742)
Metabolic disorders (115)
Neuroscience (587)
NextGen Class of 2024 (3771)
Non-profit (2943)
Northern California (690)
Obesity (56)
Opinion (68)
People (30025)
Phase I (6601)
Phase II (8328)
Phase III (6197)
Pipeline (253)
Policy (46)
Postmarket research (679)
Preclinical (3149)
Press Release (70)
Radiopharmaceuticals (116)
Rare diseases (73)
Real estate (3647)
Regulatory (8198)
Research institute (1409)
Resumes & cover letters (100)
Southern California (538)
Startups (1765)
United States (5994)
Vaccines (97)
Date
Today (40)
Last 7 days (313)
Last 30 days (1700)
Last 365 days (16368)
2024 (15042)
2023 (18872)
2022 (26301)
2021 (27528)
2020 (27120)
2019 (25660)
2018 (19376)
2017 (14750)
2016 (14081)
2015 (15835)
2014 (11449)
2013 (9614)
2012 (10545)
2011 (11252)
2010 (10093)
Location
Africa (294)
Arizona (63)
Asia (16205)
Australia (2389)
California (1420)
Canada (799)
China (127)
Colorado (88)
Connecticut (78)
Delaware (49)
Europe (39953)
Florida (180)
Illinois (185)
Indiana (133)
Japan (44)
Maryland (384)
Massachusetts (1090)
Michigan (59)
Minnesota (99)
New Jersey (400)
New York (369)
North Carolina (382)
Northern California (690)
Ohio (78)
Pennsylvania (340)
South America (466)
Southern California (538)
Texas (218)
Utah (41)
Washington State (120)
303,530 Results for "alivamab discovery services".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Ablexis and AlivaMab Discovery Services Announce Expansion of Antibody Drug Discovery and Engineering Capabilities
Ablexis, LLC and AlivaMab Discovery Services, LLC announced an expansion of platforms and capabilities in antibody drug discovery and engineering.
November 15, 2022
·
4 min read
Business
AlivaMab Discovery Services Reappoints Dr. Larry Green as Chief Executive Officer
AlivaMab Discovery Services, a leader in the discovery of superior antibody-based therapeutics, announced that Larry Green has reassumed the role of Chief Executive Officer, effective immediately.
September 23, 2022
·
2 min read
Business
AlivaMab Discovery Services Expands Discovery Agreement with IGM Biosciences
AlivaMab Discovery Services, a leader in the discovery of superior antibody therapeutics, announced an expanded agreement with IGM Biosciences.
November 1, 2021
·
2 min read
Selvita launches biologic drug discovery and development services
Selvita S.A. announced a strategic initiative to significantly expand its services portfolio and enter the field of biologic drug discovery and development, by adding comprehensive therapeutic antibody discovery and development capabilities to its portfolio.
March 18, 2024
·
4 min read
Business
AlivaMab Discovery Services Appoints Jane Seagal, PhD, as Vice President of Antibody Discovery
AlivaMab Discovery Services, LLC, a leader in the discovery of superior antibody-based therapeutics, announced Jane Seagal, PhD, has joined the company as Vice President of Antibody Discovery.
January 11, 2022
·
3 min read
News
Axcelead Drug Discovery Partners Enters into Master Service Agreement for Drug Discovery Projects with Acadia Pharmaceuticals
September 19, 2024
·
2 min read
Aurigene Pharmaceutical Services Ltd., and Vipergen announce a strategic partnership for offering DNA encoded library (DEL) screening and integrated drug discovery services.
Aurigene Pharmaceutical Services Ltd. (Aurigene), a global contract research, development, and manufacturing services organization (CRDMO), and Vipergen ApS, a niche small-molecule drug discovery service provider specialized in DEL technologies, entered into a strategic partnership.
April 19, 2024
·
3 min read
Biotech Beach
Ablexis and AlivaMab Discovery Services Announce Agreements with Almirall to Accelerate Antibody Drug Discovery and Development
Ablexis, LLC and AlivaMab Discovery Services, LLC announced a multi-target licensing agreement between Ablexis and Almirall, S.A., a global biopharmaceutical company focused on skin health, and a research partnership between ADS and Almirall.
January 31, 2022
·
5 min read
Business
AlivaMab Discovery Services Announces Multi-Target Agreement with Teva Pharmaceuticals
AlivaMab Discovery Services Announces Multi-Target Agreement with Teva Pharmaceuticals Agreement aims to accelerate the discovery of new therapeutics
September 14, 2021
·
2 min read
Business
X-Chem Strengthens Its Data-Driven Discovery Services With New CBO Appointment
Small molecule drug discovery acceleration experts and DNA-encoded library technology pioneers X-Chem, Inc. welcomes Paul Davie as Chief Business Officer.
June 20, 2024
·
2 min read
1 of 30,353
Next
